Core proteome mediated therapeutic target mining and multi-epitope vaccine design for Helicobacter pylori.

Helicobacter pylori is a Gram-negative spiral-shaped bacterium that infects half of the human population worldwide and causes chronic inflammation. In the present study, we used the art of computational biology for therapeutic drug targets identification and a multi-epitope vaccine against multi-strains of H. pylori. For drug target identification, we used different tools and softwares to identify human non-homologous but pathogen essential proteins, with virulent properties and involved in unique metabolic pathways of H. pylori. For this purpose, the core proteome of 84 strains of H. pylori was retrieved from EDGAR 2.3 database. There were 59,808 proteins sequences in these strains. Duplicates and paralogous protein sequence removal was followed by human non-homologous protein miningPathogen essential and virulent proteins were subjected to pathway analysis Subcellular localization of the virulent proteins was predicted and druggability was also checked, leading to 30 druggable targets based on their similarity with the approved drug targets in Drugbank. For immunoinformatics analysis, we selected two outer membrane proteins (HPAKL86_RS06305 and HPSNT_RS00950) and subjected to determined immunogenic B and T-Cell epitopes. The B and T-Cell overlapped epitopes were selected to design 9 different vaccine constructs by using linkers and adjuvants. Least allergenic and most antigenic construct (C-8) was selected as a promiscuous vaccine to elicit host immune response. Cloning and in silico expression of the constructed vaccine (C-8) was done to produce a clone having the desired (gene) vaccine construct. In conclusion, the prioritized therapeutic targets for 84 strains of H.pylori will be useful for future therapy design. Vaccine design may also prove useful in the quest for targeting multi-strains of H. pylori in patients. • Genome-wide core proteome of eighty-four strains of H.pylori was analysed for therapeutic drug targets and vaccine development. • 30 unique druggabble targets were predicted , which are non-homologous to host, virulent and essential for pathogen survival. • Metabolic pathways analysis was performed to identify essential and unique pathways in Helicobacter pylori. • Multi-epitope vaccine from B and T-cell epitopes by using linkers and adjuvants to enhance the immunogenicity of the vaccine. • Least allergenic and most antigenic construct was selected as a promiscuous vaccine to elicit host immune response. [ABSTRACT FROM AUTHOR]